The classic website will no longer be available as of June 25, 2024. Please use the modernized
Working… Menu

A Long-term Treatment With B-VEC for Dystrophic Epidermolysis Bullosa

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04917874
Recruitment Status : Completed
First Posted : June 8, 2021
Last Update Posted : April 9, 2024
Information provided by (Responsible Party):
Krystal Biotech, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 31, 2023
Actual Study Completion Date : July 31, 2023